Yoichi Negishi

Dr. Yoichi Negishi

Tokyo University of Pharmacy and Life Sciences

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2014 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YEYoko Endo-Takahashi
Yoko Endo-Takahashi
YNYoichi Negishi
Yoichi Negishi
ANArisa Nakamura
Arisa Nakamura
SUSaori Ukai
Saori Ukai
KOKotomi Ooaku
Kotomi Ooaku
YAYukihiko Aramaki
Yukihiko Aramaki
Currently, micro RNA (miRNA) is considered an attractive target for therapeutic intervention. A significant obstacle to the miRNA-based treatments is the efficient delivery of miRNA to the target tissue. We have developed polyethylene glycol-modified liposomes (Bubble liposomes (BLs)) that entrap ultrasound (US) contrast gas and can serve as both plasmid DNA (pDNA) or small interfering RNA (siRNA) carriers and US contrast agents. In this study, we investigated the usability of miRNA-loaded BLs (mi-BLs) using a hindlimb ischemia model and miR-126. It has been reported that miR-126 promotes angiogenesis via the inhibition of negative regulators of VEGF signaling. We demonstrated that mi-BLs could be detected using diagnostic US and that mi-BLs with therapeutic US could deliver miR-126 to an ischemic hindlimb, leading to the induction of angiogenic factors and the improvement of blood flow. These results suggest that combining mi-BLs with US may be useful for US imaging and miRNA delivery.

14 October 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YEYoko Endo-Takahashi
Yoko Endo-Takahashi
YNYoichi Negishi
Yoichi Negishi
The regulation of gene expression is a promising therapeutic approach for many intractable diseases. However, its use in clinical applications requires the efficient delivery of nucleic acids to target tissues, which is a major challenge. Recently, various delivery systems employing physical energy, such as ultrasound, magnetic force, electric force, and light, have been developed. Ultrasound-mediated delivery has particularly attracted interest due to its safety and low costs. Its delivery effects are also enhanced when combined with microbubbles or nanobubbles that entrap an ultrasound contrast gas. Furthermore, ultrasound-mediated nucleic acid delivery could be performed only in ultrasound exposed areas. In this review, we summarize the ultrasound-mediated nucleic acid systemic delivery system, using microbubbles or nanobubbles, and discuss its possibilities as a therapeutic tool.

1 January 2013 in Biomaterials
Verified
Journal Article
Closed access
YNYoichi Negishi
Yoichi Negishi
NHNobuhito Hamano
Nobuhito Hamano
YTYuka Tsunoda
Yuka Tsunoda
YOYusuke Oda
Yusuke Oda
BCBatsuren Choijamts
Batsuren Choijamts
YAYukihiko Aramaki
Yukihiko Aramaki

21 September 2015 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YNYoichi Negishi
Yoichi Negishi
MYMasaya Yamane
Masaya Yamane
NKNaho Kurihara
Naho Kurihara
YEYoko Endo-Takahashi
Yoko Endo-Takahashi
SSSanae Sashida
Sanae Sashida
KMKazuo Maruyama
Kazuo Maruyama
The blood–brain barrier (BBB) is a major obstacle that prevents therapeutic drugs or genes from being delivered to the central nervous system. Therefore, it is important to develop methods to enhance the permeability of the BBB. We have developed echo-contrast gas (C3F8) entrapping liposomes (Bubble liposomes, BLs) that can work as a gene delivery tool in combination with ultrasound (US) exposure. Here, we studied whether the permeability of the BBB can be enhanced by the combination of BLs and high-intensity focused ultrasound (HIFU). Mice were intravenously injected with Evans blue (EB). BLs were subsequently injected, and the right hemispheres were exposed to HIFU. As a result, the accumulation of EB in the HIFU-exposed brain hemispheres was increased over that observed in the non-HIFU-exposed hemispheres, depending on the intensity and the duration of the HIFU. Similarly, the combination of BLs and HIFU allowed fluorescent-labeled antisense oligonucleotides to be delivered into the HIFU-exposed left hemispheres of the treated mice. Furthermore, a firefly luciferase-expressing plasmid DNA was delivered to the brain by the combination method of BLs and HIFU, which resulted in the increased gene expression in the brain at the focused-US exposure site. These results suggest that the method of combining BLs and HIFU together serves as a useful means for accelerating the permeability of BBB and thereby enabling antisense oligonucleotides or genes to be delivered to the focused brain site.

17 May 2012 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
YNYoichi Negishi
Yoichi Negishi
YEYoko Endo-Takahashi
Yoko Endo-Takahashi
YMYuki Matsuki
Yuki Matsuki
YKYasuharu Kato
Yasuharu Kato
NTNorio Takagi
Norio Takagi
YAYukihiko Aramaki
Yukihiko Aramaki

8 October 2010 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
YNYoichi Negishi
Yoichi Negishi
KMKeiko Matsuo
Keiko Matsuo
YEYoko Endo-Takahashi
Yoko Endo-Takahashi
KSKentaro Suzuki
Kentaro Suzuki
YMYuuki Matsuki
Yuuki Matsuki
YAYukihiko Aramaki
Yukihiko Aramaki